Click here to return to the Reference Table

Category: Soft tissue sarcomas
Cancer type: MFH/Fibrosarcoma
Descriptor: Animal models

Reference Number: 64
Jeffers, M. et al. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci U S A 95, 14417-22 (1998).
PubMed link      E-mail link

Reference Number: 152
Helou, K. et al. Amplification and overexpression of the hepatocyte growth factor receptor (HGFR/MET) in rat DMBA sarcomas. Oncogene 18, 3226-34. (1999).
PubMed link      E-mail link

Reference Number: 153
Helou, K., Walentinsson, A., Kost-Alimova, M. & Levan, G. Hgfr/Met oncogene acts as target for gene amplification in DMBA-induced rat sarcomas: free chromatin fluorescence in situ hybridization analysis of amplicon arrays in homogeneously staining regions. Genes Chromosomes Cancer 30, 416-20. (2001).
PubMed link      E-mail link

Reference Number: 154
Rong, S. et al. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res 55, 1963-70 (1995).
PubMed link      E-mail link

Reference Number: 155
Webb, C. P. et al. Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis. Oncogene 17, 2019-25 (1998).
PubMed link      E-mail link

Reference Number: 349
Sjoling A, Walentinsson A, Nordlander C, Karlsson A, Behboudi A, Samuelson E, Levan G, Rohme D. Assessment of allele dosage at polymorphic microsatellite loci displaying allelic imbalance in tumors by means of quantitative competitive-polymerase chain reaction. Cancer Genet Cytogenet157, 97-103 (2005)
PubMed link      E-mail link